Detection of Fast Decliner of Diabetic Kidney Disease Using Chiral Amino Acid Profiling: A Pilot Study
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202403332 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Yosuke Hirakawa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Endocrinology, the University of Tokyo Graduate School of Medicine, Bunkyo-ku, Japan. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Amino Acids. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Center of Innovation Science and Technology-based Radical Innovation and Entrepreneurship Program (COI STREAM).
Abstract (Originalsprache)
Biomarkers for the prediction of diabetic kidney disease are still unsatisfactory. Although D‐amino acids have been shown to reflect kidney conditions, their efficacy in treating diabetic kidney disease (DKD) has not been demonstrated. This study explored the potential role of D‐amino acids as progression markers for DKD, an aspect not addressed previously. We performed comprehensive D‐amino acid measurements and collected the longitudinal estimated glomerular filtration rate (eGFR) data of 135 patients. We defined fast decliners (FDs) as patients exhibiting >10% decline from baseline eGFR per year and compared the D‐amino acid levels of FDs and non‐FDs. Then, we verified that D‐amino acids could predict FDs independent of creatinine levels. In patients with diabetic kidney disease, D‐serine, D‐alanine, and D‐proline were only detected in the blood, while 15 D‐amino acids were detected in the urine. Using supervised orthogonal partial least squares analysis, blood D‐serine and urine D‐amino acid levels were identified as features characterizing diabetic kidney disease. Baseline blood D‐serine levels and ratios did not differ between the FD and non‐FD groups; however, short‐term changes in blood D‐serine levels differed. This study emphasized the significance of D‐serine as a prognostic marker for DKD, an aspect not identified in previous research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology and Endocrinology, the University of Tokyo Graduate School of Medicine, Bunkyo-ku, Japan.
- Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan.
- KAGAMI, Inc., Ibaraki, Japan.
- Division of Chronic Kidney Disease Pathophysiology, The University of Tokyo Graduate School of Medicine, Bunkyo-ku, Japan.
ORCID-Profile: Yosuke Hirakawa, Reiko Inagi
Förderung
- Center of Innovation Science and Technology-based Radical Innovation and Entrepreneurship Program (COI STREAM)
Zitieren
APA
Hirakawa, Y., Kimura, T., Sakai, S., Mizui, M., Mita, M., Isaka, Y., Nangaku, M., & Inagi, R. (2025). Detection of Fast Decliner of Diabetic Kidney Disease Using Chiral Amino Acid Profiling: A Pilot Study. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202403332
Vancouver
Hirakawa Y, Kimura T, Sakai S, Mizui M, Mita M, Isaka Y, et al. Detection of Fast Decliner of Diabetic Kidney Disease Using Chiral Amino Acid Profiling: A Pilot Study. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202403332
BibTeX
@article{Hirakawa2025,
author = {Hirakawa, Yosuke and Kimura, Tomonori and Sakai, Shinsuke and Mizui, Masayuki and Mita, Masashi and Isaka, Yoshitaka and Nangaku, Masaomi and Inagi, Reiko},
title = {Detection of Fast Decliner of Diabetic Kidney Disease Using Chiral Amino Acid Profiling: A Pilot Study},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202403332}
}
EUVIMED